½ÃÀ庸°í¼­
»óǰÄÚµå
1401126

ÇコÄɾî¿ë µðÁöÅÐ Æ®À© ½ÃÀå : ¼¼°è ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®, ±âȸ, ¿¹Ãø ¸®Æ÷Æ®(2019-2029³â)

Digital Twins in Healthcare Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Application ; By End User ; By Region

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Blueweave Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 400 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÇコÄɾî¿ë µðÁöÅÐ Æ®À© ½ÃÀå ±Ô¸ð°¡ CAGR 43.2%·Î 37¹è·Î ±ÞÈ®´ëÇϸç, 2029³â±îÁö 395¾ï 6,000¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

¼¼°è ÇコÄÉ¾î µðÁöÅÐ Æ®À© ½ÃÀåÀº IoT, AI µî ÷´Ü ±â¼ú Ȱ¿ëÀ» Áö¿øÇÏ´Â µðÁöÅÐ ±â¾÷ Áõ°¡¿Í ÇコÄÉ¾î »ê¾÷ÀÇ µðÁöÅÐÈ­¸¦ ÃËÁøÇÏ´Â Á¤ºÎ Áö¿ø ÇÁ·Î±×·¥ µîÀ¸·Î ÀÎÇØ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

Àü·« ÄÁ¼³ÆÃ ¹× ½ÃÀå Á¶»ç Àü¹® ±â¾÷ BlueWeave ConsultingÀº ÃÖ±Ù Á¶»ç¿¡¼­ 2023-2029³â 2023³â±îÁöÀÇ ¿¹Ãø ±â°£ Áß 2022³â ÀÇ·á ºÐ¾ß µðÁöÅÐ Æ®À© ¼¼°è ½ÃÀå ±Ô¸ð¸¦ 10¾ï 7,000¸¸ ´Þ·¯·Î ÃßÁ¤Çß½À´Ï´Ù. BlueWeave´Â ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ¼¼°è ½ÃÀå ±Ô¸ð°¡ ¿¬Æò±Õ 43.2%·Î ºü¸£°Ô ¼ºÀåÇÏ¿© 2029³â¿¡´Â 395¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. »ç¹°ÀÎÅͳÝ(IoT), ÀΰøÁö´É(AI) µî Çõ½Å ±â¼ú µµÀÔÀ» Áö¿øÇÏ´Â µðÁöÅÐ ±â¾÷ Áõ°¡¿Í ÇコÄÉ¾î ºÐ¾ßÀÇ µðÁöÅÐÈ­¸¦ À§ÇÑ ÀÚ±Ý Áö¿ø ¹× ÅõÀÚ µî Á¤ºÎÀÇ Áö¿øÃ¥ÀÌ ¼¼°è ÇコÄÉ¾î µðÁöÅÐ Æ®À© ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

±âȸº° ¸ÂÃãÄ¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

ÇコÄÉ¾î ºÐ¾ß¿¡¼­ µðÁöÅÐ Æ®À©ÀÇ È°¿ëÀº ȯÀÚ¿¡°Ô ¸ÂÃãÇü Ä¡·á¿Í Åõ¾àÀ» Á¦°øÇÏ´Â ¼ö´ÜÀ¸·Î Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á Àü¹®°¡µéÀº µðÁöÅÐ Æ®À©À» »ç¿ëÇÏ¿© ȯÀÚÀÇ Æ¯Á¤ µ¥ÀÌÅ͸¦ »ç¿ëÇÏ¿© ȯÀÚ Àå±âÀÇ °¡»ó ¸ðµ¨À» °³¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °¡»ó Àå±â¸¦ ÅëÇØ ÀÇ·á Àü¹®°¡µéÀº µðÁöÅÐ Æ®À©°ú ¹°¸®Àû Æ®À©ÀÇ Â÷ÀÌÁ¡À» ±â¹ÝÀ¸·Î ƯÁ¤ Ä¡·á¿¡ ´ëÇÑ Àå±âÀÇ ¹ÝÀÀÀ» Æò°¡ÇÏ°í ¿¹ÃøÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ÀÇ·áÁøÀº °³ÀÎÈ­µÈ ¿¹Ãø ÀǷḦ Á¦°øÇÒ ¼ö ÀÖÀ¸¸ç, ȹÀÏÀûÀÎ ÀÇ·á Á¢±Ù ¹æ½Ä¿¡¼­ ¹þ¾î³¯ ¼ö ÀÖ½À´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¼¼°è ÇコÄÉ¾î µðÁöÅÐ Æ®À© ½ÃÀå¿¡ À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇコÄÉ¾î ºÐ¾ß µðÁöÅÐ Æ®À© ¼¼°è ½ÃÀå - ¿ëµµº°

ÇコÄÉ¾î µðÁöÅÐ Æ®À© ¼¼°è ½ÃÀåÀº ¿ëµµº°·Î ½Å¾à°³¹ß ¹× ½ÃÀ尳ô, ¸ÂÃãÀÇ·á, Ä¡·á°èȹ, À§Çè°ü¸®, ÀÇ·á ¿öÅ©Ç÷οì ÃÖÀûÈ­, ±âŸ·Î ³ª´¹´Ï´Ù. ÇコÄÉ¾î µðÁöÅÐ Æ®À© ¼¼°è ½ÃÀå¿¡¼­ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÏ´Â ºÐ¾ß´Â °³ÀÎ ¸ÂÃãÇü ÀÇ·á ºÐ¾ß·Î, Nature Journal¿¡ °ÔÀçµÈ ³í¹®¿¡ µû¸£¸é ÇコÄɾ µðÁöÅÐ Æ®À©À» µµÀÔÇϸé ÀÇ·áÁøÀº Áúº´À» Áø´ÜÇϰí Ä¡·áÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¾à¹°¿¡ ´ëÇÑ È¯ÀÚÀÇ ¹ÝÀÀÀ» ¿¹ÃøÇÒ ¼ö ÀÖ´Ù°í ÇÕ´Ï´Ù. ¿¹ÃøÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁöÁ¤ÇÐÀû ±äÀåÀÌ ³ô¾ÆÁö´Â °ÍÀÌ ¼¼°è ÇコÄÉ¾î µðÁöÅÐ Æ®À© ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

ÁöÁ¤ÇÐÀû ±äÀåÀÇ ½ÉÈ­´Â ¼¼°è ÇコÄÉ¾î µðÁöÅÐ Æ®À© ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î À̽º¶ó¿¤°ú ÆÈ·¹½ºÅ¸ÀÎÀÇ ÀüÀïÀº À̽º¶ó¿¤¿¡ »Ñ¸®¸¦ µÐ ÇコÄÉ¾î ºÐ¾ßÀÇ µðÁöÅÐ Æ®À©À» Æ÷ÇÔÇÑ Ã·´Ü ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ¿Í R&D Ȱµ¿À» ¹æÇØÇϰí ÀÖ½À´Ï´Ù. À̽º¶ó¿¤Àº ¸¶ÀÌÅ©·Î¼ÒÇÁÆ®, ±¸±Û µî ÁÖ¿ä ±â¼ú ±â¾÷À» À§ÇÑ ÇÁ·Î¼¼¼­¿Í Ĩ¼ÂÀÇ ÁÖ¿ä »ý»ê±¹À̸ç, 2022³â À̽º¶ó¿¤ÀÇ ÇÏÀÌÅ×Å© »ê¾÷Àº À̽º¶ó¿¤ Àüü ¼öÃâ ¼öÀÔÀÇ 48.3%ÀÎ 710¾ï ´Þ·¯¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯¸®ÇÑ Á¤ºÎ Á¤Ã¥°ú ÅõÀÚ´Â À¯´ë ±¹°¡ÀÇ ±â¼ú Çõ½Å°ú ±â¼ú ºÎ¹®ÀÇ È®Àå¿¡ Å©°Ô ±â¿©Çß½À´Ï´Ù. ±×·¯³ª ºÐÀïÀÌ ½ÉÈ­µÇ°í È®´ëµÊ¿¡ µû¶ó ÅõÀÚÀÚµéÀº ÇÏÀÌÅ×Å© ±â¾÷¿¡¼­ ÅõÀÚ Ã¶¼ö¸¦ °í·ÁÇÒ ¼ö ÀÖÀ¸¸ç, ÀÌ´Â ÇコÄɾî R&D ºÐ¾ßÀÇ µðÁöÅÐ Æ®À©À» ¾àÈ­½Ãų ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ À̽º¶ó¿¤¿¡´Â À¯·ÂÇÑ µðÁöÅÐ ½ºÅ¸Æ®¾÷ ±â¾÷µµ ÀÖ½À´Ï´Ù. ÀÌ ±â¾÷Àº ÅõÀÚ¸¦ ¹ÞÁö ¸øÇØ ÀϽÃÀûÀ¸·Î »ç¾÷À» Áß´ÜÇØ¾ß ÇÏ´Â »óȲ¿¡ Ã³ÇØ ÀÖ½À´Ï´Ù. µû¶ó¼­ ÀüÀïÀÌ °è¼Ó È®´ëµÇ°Å³ª ±âŸ Áö¿ªÀ¸·Î È®»êµÉ °æ¿ì, ÇコÄÉ¾î ½ÃÀåÀÇ ¼¼°è µðÁöÅÐ Æ®À© ½ÃÀå È®´ë°¡ ¾ïÁ¦µÉ ¼ö ÀÖ½À´Ï´Ù.

°æÀï ±¸µµ

¼¼°è ÇコÄÉ¾î µðÁöÅÐ Æ®À© ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷À¸·Î´Â Siemens Healthineers AG, Dassault Systemes, Microsoft, Koninklijke Philips N.V., Faststream Technologies, IBM, NVIDIA Corporation, GE Healthcare, NUREA Rescale, Inc. µîÀÌ ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À²À» ´õ¿í ³ôÀ̱â À§ÇØ ÀÌµé ±â¾÷Àº M&A, ÆÄÆ®³Ê½Ê, ÇÕÀÛÅõÀÚ, ¶óÀ̼±½º °è¾à, ½ÅÁ¦Ç° Ãâ½Ã µî ´Ù¾çÇÑ Àü·«À» äÅÃÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è ÇコÄɾîÀÇ µðÁöÅÐ Æ®À© ½ÃÀåÀÇ ¼ºÀå ÀáÀç·Â, ÇâÈÄ µ¿Çâ ¹× ¼¼°è µðÁöÅÐ Æ®À© ½ÃÀå¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ºÐ¼® Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ Àüü ½ÃÀå ±Ô¸ð ¿¹ÃøÀ» ÃËÁøÇÏ´Â ¿äÀεµ ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ º¸°í¼­´Â ¼¼°è ÇコÄÉ¾î µðÁöÅÐ Æ®À© ½ÃÀåÀÇ ÃÖ±Ù ±â¼ú µ¿Çâ°ú ÀÇ»ç°áÁ¤ÀÚ°¡ °ÇÀüÇÑ Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ´Â ¾÷°è ÀλçÀÌÆ®À» Á¦°øÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, °æÀï¿¡ ´ëÇØ¼­µµ ºÐ¼®ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ÇÁ·¹ÀÓ¿öÅ©

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼¼°èÀÇ ÇコÄɾî¿ë µðÁöÅÐ Æ®À© ½ÃÀå ÀλçÀÌÆ®

  • ¾÷°èÀÇ ¹ë·ùüÀÎ ºÐ¼®
  • DROC ºÐ¼®
    • ¼ºÀå ÃËÁø¿äÀÎ
      • µðÁöÅÐ Æ®À©¿¡ ´ëÇÑ ÅõÀÚÀÇ Áõ°¡
      • ¿î¿µ È¿À²
    • ¾ïÁ¦¿äÀÎ
      • °í¾×ÀÇ µµÀÔ ºñ¿ë
      • ÇÑÁ¤ÀûÀΠäÅÃ
    • ±âȸ
      • ¸ÂÃãÇü ÀÇ·á
      • AI°ú ºÐ¼®ÀÇ ÅëÇÕ
    • °úÁ¦
      • µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã
      • µ¥ÀÌÅÍ Ç°Áú
  • ±â¼úÀÇ Áøº¸/ÃÖ±Ù °³¹ß
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ÇコÄɾî¿ë µðÁöÅÐ Æ®À© ½ÃÀå °³¿ä

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2019-2029³â
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • ¿ëµµº°
      • Drug Discovery¿Í °³¹ß
      • ¸ÂÃãÇü ÀÇ·á
      • Ä¡·á °èȹ
      • À§±â °ü¸®
      • ÇコÄÉ¾î ¿öÅ©Ç÷οìÀÇ ÃÖÀûÈ­
      • ±âŸ
    • ÃÖÁ¾»ç¿ëÀÚº°
      • Á¦¾àȸ»ç
      • ¿¬±¸±â°ü
      • ÀÇ·á±â±â ±â¾÷
      • ±âŸ
    • Áö¿ªº°
      • ºÏ¹Ì
      • À¯·´
      • ¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
      • ¶óƾ¾Æ¸Þ¸®Ä«(LATAM)
      • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)

Á¦5Àå ºÏ¹ÌÀÇ ÇコÄɾî¿ë µðÁöÅÐ Æ®À© ½ÃÀå

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2019-2029³â
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù

Á¦6Àå À¯·´ÀÇ ÇコÄɾî¿ë µðÁöÅÐ Æ®À© ½ÃÀå

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2019-2029³â
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
      • µ¶ÀÏ
      • ¿µ±¹
      • ÀÌÅ»¸®¾Æ
      • ÇÁ¶û½º
      • ½ºÆäÀÎ
      • º§±â¿¡
      • ·¯½Ã¾Æ
      • ³×´ú¶õµå
      • ±âŸ

Á¦7Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇコÄɾî¿ë µðÁöÅÐ Æ®À© ½ÃÀå

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2019-2029³â
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
      • Áß±¹
      • Àεµ
      • ÀϺ»
      • Çѱ¹
      • È£ÁÖ¿Í ´ºÁú·£µå
      • Àεµ³×½Ã¾Æ
      • ¸»·¹À̽þÆ
      • ½Ì°¡Æ÷¸£
      • º£Æ®³²
      • ±âŸ

Á¦8Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ÇコÄɾî¿ë µðÁöÅÐ Æ®À© ½ÃÀå

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2019-2029³â
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
      • ºê¶óÁú
      • ¸ß½ÃÄÚ
      • ¾Æ¸£ÇîÆ¼³ª
      • Æä·ç
      • ±âŸ

Á¦9Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÇコÄɾî¿ë µðÁöÅÐ Æ®À© ½ÃÀå

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2019-2029³â
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ¾Æ¶ø¿¡¹Ì¸®Æ®
      • īŸ¸£
      • Äí¿þÀÌÆ®
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
      • ³ªÀÌÁö¸®¾Æ
      • ¾ËÁ¦¸®
      • ±âŸ

Á¦10Àå °æÀï ±¸µµ

  • ÁÖ¿ä ±â¾÷°ú Á¦Ç° ¸®½ºÆ®
  • ÇコÄÉ¾î ½ÃÀå Á¡À¯À² ºÐ¼®¿¡¼­ ¼¼°èÀÇ µðÁöÅÐ Æ®À©, 2022³â
  • °æ¿µ ÆÄ¶ó¹ÌÅÍ¿¡ ÀÇÇÑ °æÀï º¥Ä¡¸¶Å·
  • ÁÖ¿ä Àü·«Àû °³¹ß(ÇÕº´, Àμö, ÆÄÆ®³Ê½Ê µî)

Á¦11Àå ¼¼°èÀÇ ÇコÄɾî¿ë µðÁöÅÐ Æ®À© ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦12Àå ±â¾÷ °³¿ä(ȸ»ç °³¿ä, À繫 ¸ÅÆ®¸¯½º, °æÀï ±¸µµ, ÁÖ¿äÀÎÀç, ÁÖ¿ä °æÀï, ¿¬¶ôó ÁÖ¼Ò, Àü·«Àû Àü¸Á, SWOT ºÐ¼®)

  • Siemens Healthineers AG
  • Dassault Systemes
  • Microsoft
  • Koninklijke Philips NV
  • Faststream Technologies
  • IBM
  • NVIDIA Corporation
  • GE Healthcare
  • NUREA Rescale, Inc.
  • ±âŸ ÁÖ¿ä ±â¾÷

Á¦13Àå ÁÖ¿ä Àü·«Àû Á¦¾È

Á¦14Àå Á¶»ç ¹æ¹ý

KSA 24.01.09

Global Digital Twins in Healthcare Market Size Zooming 37X at Robust CAGR of 43.2% to Touch Whopping USD 39.56 Billion by 2029

Global Digital Twins in Healthcare market is gaining traction because of the increasing number of digital firms supporting the use of cutting-edge technologies, including IoT and AI, in conjunction with supportive government programs to digitize the healthcare industry.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Digital Twins in Healthcare Market size at USD 1.07 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the Global Digital Twins in Healthcare Market size to boom at a CAGR of 43.2% reaching a value of USD 39.56 billion by 2029. A growing number of digital companies supporting the adoption of innovative technologies, such as Internet of Things (IoT) and artificial intelligence (AI), as well as supportive government initiatives, like funding and investments, to digitize the healthcare sector, are key growth factors for the global digital twins in healthcare market.

Opportunity: Rising Demand for Personalized Treatment

The use of digital twins in the healthcare sector is growing significantly as a means of giving patients personalized treatment and medication. Healthcare professionals can employ digital twins to develop virtual models of their patient's organs using the patient's specific data. By using these virtual organs, medical professionals can assess and forecast an organ's response to a specific treatment based on the differences between the digital and physical twins. It enables them to provide individualized and predictive care, doing away with the one-size-fits-all approach to healthcare. The rising demand for personalized medicine is anticipated to present lucrative growth opportunities to the global digital twins in healthcare market.

Global Digital Twins in Healthcare Market - By Application

Based on application, the Global Digital Twins in Healthcare Market is segmented into drug discovery & development, personalized medicine, treatment planning, risk management, healthcare workflow optimization, and others. The personalized medicine segment holds the largest share of the Global Digital Twins In Healthcare Market. According to an editorial published in Nature Journal, the implementation of digital twins in healthcare not only allows healthcare practitioners to diagnose and treat disease but also helps forecast patient response to medication.

Impact of Escalating Geopolitical Tensions on Global Digital Twins in Healthcare Market

The escalating geopolitical tensions may disrupt the growth of the Global Digital Twins In The Healthcare Market. For instance, the Israel-Palestine war has hindered investments and research and development activities of advanced technologies, including digital twins in healthcare, that have strong roots in Israel. Israel is a leading producer of processors and chipsets for leading technology corporations, including Microsoft and Google. In 2022, the high-tech industry in Israel constituted 48.3% of Israel's total export earnings, or USD 71 billion. The favorable government policies and investments contributed significantly to expanding the innovation and technology sector in the Jewish state. But as the conflict has intensified and been escalating, investors may consider withdrawing their investments from tech firms, which could weaken the digital twins in the field of healthcare research and development. Israel is also home to leading digital startups. As a result, these firms' inability to get investments forced them to temporarily halt their operations. Hence, if the war continues to escalate or spread to other regions, it could restrain the expansion of the Global Digital Twin Market in Healthcare Market.

Competitive Landscape

Major players operating in the Global Digital Twins in Healthcare Market include Siemens Healthineers AG, Dassault Systemes, Microsoft, Koninklijke Philips N.V., Faststream Technologies, IBM, NVIDIA Corporation, GE Healthcare, and NUREA Rescale, Inc.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Digital Twins in Healthcare Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Digital Twins in Healthcare Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Digital Twins in Healthcare Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Investments in Digital Twins
      • 3.2.1.2. Operational Efficiency
    • 3.2.2. Restraints
      • 3.2.2.1. High Implementation Costs
      • 3.2.2.2. Limited Adoption
    • 3.2.3. Opportunities
      • 3.2.3.1. Personalized Medicine
      • 3.2.3.2. AI and Analytics Integration
    • 3.2.4. Challenges
      • 3.2.4.1. Data Privacy
      • 3.2.4.2. Data Quality
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Digital Twins in Healthcare Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Billion)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Application
      • 4.2.1.1. Drug Discovery & Development
      • 4.2.1.2. Personalized Medicine
      • 4.2.1.3. Treatment Planning
      • 4.2.1.4. Risk Management
      • 4.2.1.5. Healthcare Workflow Optimization
      • 4.2.1.6. Others
    • 4.2.2. By End User
      • 4.2.2.1. Pharmaceutical Companies
      • 4.2.2.2. Research Institutions
      • 4.2.2.3. Medical Device Companies
      • 4.2.2.4. Others
    • 4.2.3. By Region
      • 4.2.3.1. North America
      • 4.2.3.2. Europe
      • 4.2.3.3. Asia Pacific (APAC)
      • 4.2.3.4. Latin America (LATAM)
      • 4.2.3.5. Middle East and Africa (MEA)

5. North America Digital Twins in Healthcare Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application
    • 5.2.2. By End User
    • 5.2.3. By Country
      • 5.2.3.1. United States
      • 5.2.3.1.1. By Application
      • 5.2.3.1.2. By End User
      • 5.2.3.2. Canada
      • 5.2.3.2.1. By Application
      • 5.2.3.2.2. By End User

6. Europe Digital Twins in Healthcare Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By End User
    • 6.2.3. By Country
      • 6.2.3.1. Germany
      • 6.2.3.1.1. By Application
      • 6.2.3.1.2. By End User
      • 6.2.3.2. United Kingdom
      • 6.2.3.2.1. By Application
      • 6.2.3.2.2. By End User
      • 6.2.3.3. Italy
      • 6.2.3.3.1. By Application
      • 6.2.3.3.2. By End User
      • 6.2.3.4. France
      • 6.2.3.4.1. By Application
      • 6.2.3.4.2. By End User
      • 6.2.3.5. Spain
      • 6.2.3.5.1. By Application
      • 6.2.3.5.2. By End User
      • 6.2.3.6. Belgium
      • 6.2.3.6.1. By Application
      • 6.2.3.6.2. By End User
      • 6.2.3.7. Russia
      • 6.2.3.7.1. By Application
      • 6.2.3.7.2. By End User
      • 6.2.3.8. The Netherlands
      • 6.2.3.8.1. By Application
      • 6.2.3.8.2. By End User
      • 6.2.3.9. Rest of Europe
      • 6.2.3.9.1. By Application
      • 6.2.3.9.2. By End User

7. Asia-Pacific Digital Twins in Healthcare Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By End User
    • 7.2.3. By Country
      • 7.2.3.1. China
      • 7.2.3.1.1. By Application
      • 7.2.3.1.2. By End User
      • 7.2.3.2. India
      • 7.2.3.2.1. By Application
      • 7.2.3.2.2. By End User
      • 7.2.3.3. Japan
      • 7.2.3.3.1. By Application
      • 7.2.3.3.2. By End User
      • 7.2.3.4. South Korea
      • 7.2.3.4.1. By Application
      • 7.2.3.4.2. By End User
      • 7.2.3.5. Australia & New Zealand
      • 7.2.3.5.1. By Application
      • 7.2.3.5.2. By End User
      • 7.2.3.6. Indonesia
      • 7.2.3.6.1. By Application
      • 7.2.3.6.2. By End User
      • 7.2.3.7. Malaysia
      • 7.2.3.7.1. By Application
      • 7.2.3.7.2. By End User
      • 7.2.3.8. Singapore
      • 7.2.3.8.1. By Application
      • 7.2.3.8.2. By End User
      • 7.2.3.9. Vietnam
      • 7.2.3.9.1. By Application
      • 7.2.3.9.2. By End User
      • 7.2.3.10. Rest of APAC
      • 7.2.3.10.1. By Application
      • 7.2.3.10.2. By End User

8. Latin America Digital Twins in Healthcare Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By End User
    • 8.2.3. By Country
      • 8.2.3.1. Brazil
      • 8.2.3.1.1. By Application
      • 8.2.3.1.2. By End User
      • 8.2.3.2. Mexico
      • 8.2.3.2.1. By Application
      • 8.2.3.2.2. By End User
      • 8.2.3.3. Argentina
      • 8.2.3.3.1. By Application
      • 8.2.3.3.2. By End User
      • 8.2.3.4. Peru
      • 8.2.3.4.1. By Application
      • 8.2.3.4.2. By End User
      • 8.2.3.5. Rest of LATAM
      • 8.2.3.5.1. By Application
      • 8.2.3.5.2. By End User

9. Middle East and Africa Digital Twins in Healthcare Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By End User
    • 9.2.3. By Country
      • 9.2.3.1. Saudi Arabia
      • 9.2.3.1.1. By Application
      • 9.2.3.1.2. By End User
      • 9.2.3.2. UAE
      • 9.2.3.2.1. By Application
      • 9.2.3.2.2. By End User
      • 9.2.3.3. Qatar
      • 9.2.3.3.1. By Application
      • 9.2.3.3.2. By End User
      • 9.2.3.4. Kuwait
      • 9.2.3.4.1. By Application
      • 9.2.3.4.2. By End User
      • 9.2.3.5. South Africa
      • 9.2.3.5.1. By Application
      • 9.2.3.5.2. By End User
      • 9.2.3.6. Nigeria
      • 9.2.3.6.1. By Application
      • 9.2.3.6.2. By End User
      • 9.2.3.7. Algeria
      • 9.2.3.7.1. By Application
      • 9.2.3.7.2. By End User
      • 9.2.3.8. Rest of MEA
      • 9.2.3.8.1. By Application
      • 9.2.3.8.2. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Digital Twins in Healthcare Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Digital Twins in Healthcare Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Siemens Healthineers AG
  • 12.2. Dassault Systemes
  • 12.3. Microsoft
  • 12.4. Koninklijke Philips N.V.
  • 12.5. Faststream Technologies
  • 12.6. IBM
  • 12.7. NVIDIA Corporation
  • 12.8. GE Healthcare
  • 12.9. NUREA Rescale, Inc.
  • 12.10. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦